- 专利标题： Tricyclic quinoline and quinoxaline derivatives
-
申请号： US14026354申请日： 2013-09-13
-
公开(公告)号： US10118926B2公开(公告)日： 2018-11-06
- 发明人: Hannes Koolman , Wilfried Braje , Helmut Mack , Andreas Haupt , Ana Lucia Relo , Karla Drescher , Margaretha Henrica Maria Bakker , Viktor Lakics , Carolin Hoft , Ruxu Xu , Xiaona Zhao
- 申请人： AbbVie Deutschland GmbH & Co. KG , AbbVie Inc.
- 申请人地址： DE Wiesbaden US IL North Chicago
- 专利权人： ABBVIE DEUTSCHLAND GMBH & CO. KG,ABBVIE INC.
- 当前专利权人： ABBVIE DEUTSCHLAND GMBH & CO. KG,ABBVIE INC.
- 当前专利权人地址： DE Wiesbaden US IL North Chicago
- 代理机构： Neal, Gerber & Eisenberg LLP
- 优先权： CN201310410951 20130911
- 主分类号： A61K31/551
- IPC分类号： A61K31/551 ; C07D471/06 ; C07D487/16 ; C07D487/06
摘要：
The present invention relates to tricyclic quinoline and quinoxaline derivatives, to a pharmaceutical composition containing such compounds, to their use as modulators, especially agonists or partial agonists, of the 5-HT2C receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of 5-HT2C receptor, and to a method for preventing or treating conditions and disorders which respond to the modulation of 5-HT2C receptor.
公开/授权文献
- US20140080816A1 TRICYCLIC QUINOLINE AND QUINOXALINE DERIVATIVES 公开/授权日：2014-03-20
信息查询
